Bristol’s Checkmate-331 Failure Not Likely To Endanger SCLC Labeling For Opdivo

 
• By Joseph Haas
  
Digital illustration of lung cancer cells in color background
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer